Cited 35 times in

Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients

Authors
 J.H. Kim ; Y.H. Kim ; S.-C. Kim ; M.R. Kim 
Citation
 British Journal of Dermatology, Vol.165(3) : 646~651, 2011 
Journal Title
 British Journal of Dermatology 
ISSN
 0007-0963 
Issue Date
2011
Abstract
BACKGROUND: The treatment of pemphigus is still challenging and some patients with pemphigus are unresponsive to conventional immunosuppressive treatments. Rituximab, a chimeric monoclonal anti-CD20 antibody, binds to the CD20 antigen on the surface of B cells and has been reported to be effective for the treatment of recalcitrant pemphigus. OBJECTIVE: To compare the efficacy of different doses of rituximab in patients with pemphigus who were unresponsive to conventional therapies. METHODS: Twenty-seven patients with pemphigus who received different doses of rituximab (375 mg m(-2) per infusion weekly) were analysed retrospectively. We divided the patients into two groups: group 1 (n = 12) received two infusions of rituximab and group 2 (n = 15) received three or more infusions of rituximab at 1-week intervals. The number of infusions was determined by the choice of each patient. The endpoints of the study were time to disease control, partial remission (PR) and complete remission (CR). RESULTS: There was no significant difference in time to achieve PR between the two groups (147 vs. 135 days, P = 0·65). However, group 2 demonstrated better outcomes than group 1 in time to CR (443 vs. 149 days, P = 0·06) and relapse rate (0% vs. 67%, P < 0·01). CONCLUSIONS: We conclude that three or more infusions of rituximab are more effective than two infusions for the treatment of pemphigus. © 2011 The Authors. BJD © 2011 British Association of Dermatologists.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/94307
DOI
10.1111/j.1365-2133.2011.10411.x
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Dermatology
Yonsei Authors
사서에게 알리기
  feedback
Link
 http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2011.10411.x/abstract
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse